Stian Kildal

Chief Executive Officer

C-suiteM

FI·FIN-FSA

OncoZenge AB OncoZenge AB

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Stian Kildal, Chief Executive Officer. Officer active across 2 companies, notably OncoZenge AB. Aggregated, 3 filings have been published. The latest transaction was disclosed on 28 November 2025 (Purchase). Regulator: FIN-FSA. The full history is free.

Declarations3 total

Executives●PurchaseOOncoZenge AB◆Signal · 47FIN-FSA

S

Stian KildalVerkställande direktör (VD)

€36,15874,999 shares@ €0.48210.039% mcap76.8% of flow

Aktie

FI:A003U252-1·28 Nov 2025

Ideal exit: 25 Aug 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseOOncoZenge AB34FIN-FSA

S

Stian KildalVerkställande direktör (VD)

€14,33325,000 shares@ €0.57330.015% mcap100.0% of flow

Aktie

FI:A003S148-1·9 Sept 2025

Ideal exit: 6 Jun 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseOOncoZenge AB28FIN-FSA

S

Stian KildalVerkställande direktör (VD)

€10,94920,000 shares@ €0.54740.012% mcap23.2% of flow

Aktie

FI:A003N025-2·28 Mar 2025

Ideal exit: 23 Dec 2025 (T+270)

FIN-FSA ↗

3 of 3 declarations

About Stian Kildal

Stian Kildal is the CEO of OncoZenge AB. He is responsible for the strategic direction and daily management of the company. With experience in the biotechnology field, Stian strives to promote innovation and growth within OncoZenge AB.